genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
Topics
Genome Editing
Page 3
Genome Editing
Artificial Intelligence
Bioprocessing
Cancer
Coronavirus
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Random
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Genome Editing
Successful Step Made toward Synthetic Genomes
Genome Editing
Oxford BioMedica to Obtain $250K to Support Gene Therapy for Stargardt Disease
Genome Editing
IDT Purchases VH Bio’s Oligo Segment
Genome Editing
Scientists Create Targeted Knockout Rats Using Sangamo’s Zinc Finger Nuclease Technology
Genome Editing
DNA2.0 Reveals Intricacies Involved in Optimized Gene Design
Genome Editing
EMA Launches Program to Help Firms with Advanced Therapeutics Negotiate Regulatory...
Genome Editing
Plasticell and Sigma-Aldrich Partner on Stem Cell Differentiation Tools
Genome Editing
Amsterdam Molecular Therapeutics Gains Additional Rights to Amgen GDNF Gene
Genome Editing
MorphoSys’ Sloning Business to Install Library Platform at Pfizer’s Rinat Subsidiary
Genome Editing
Sigma Creates Knockin Rats with ZFN Technology
Genome Editing
Presidential Bioethics Commission Releases Review of Synthetic Biology
Genome Editing
Researchers Develop Simpler, Quicker Way of Producing AAV-Based Vectors for Gene...
Genome Editing
Intrexon Makes $11.63M Equity Payment in Ziopharm as Part of DNA-Based...
Genome Editing
Synthetic Proteins that Sustain Life Created
Genome Editing
AMT Secures Option to License Sanfilippo B Gene Therapy from Institut...
1
2
3
4
...
186
Page 3 of 186
Scroll Up
Scroll Up
![Firms will combine CompoZr and CombiCult platforms to develop ESC and iPSC protocols.[iStockphoto]](https://www.genengnews.com/wp-content/uploads/2018/08/UGENWebsitepicturesTopStoriesNov2010Nov29_2010_StemCellsInDish_10601978_PlastiCellSigmaCollab1635992453-324x160.jpg "Plasticell and Sigma-Aldrich Partner on Stem Cell Differentiation Tools")
![SAGE Labs plans on offering off-the-shelf and custom models.[Pakhnyushchyy-Fotolia.com]](https://www.genengnews.com/wp-content/uploads/2018/08/UGENWebsitepicturesTopStoriesDec2010Dec13_2010_11259247_Mouse_SigmaZFNknockinRats9216822924-324x160.jpg "Sigma Creates Knockin Rats with ZFN Technology")
![Recommendations include federal oversight but do not put major restrictions on research.[Orlando Florin Rosu-Fotolia.com]](https://www.genengnews.com/wp-content/uploads/2018/08/UGENWebsitepicturesTopStoriesDec2010Dec16_2010_9803664_RedWhiteDNALinkingUp_MoreGovOversightForSyntheticBio1441213511-324x160.jpg "Presidential Bioethics Commission Releases Review of Synthetic Biology")
![Partnership provides Ziopharm with rights to UltraVector platform and two clinical-stage oncology candidates.[ktsdesign-Fotolia.com]](https://www.genengnews.com/wp-content/uploads/2018/08/UGENWebsitepicturesTopStoriesJan2011Jan7_2010_3986080_PurpleBlueDNAStripes_ZioPharmIntrexonSyntheticBioCollab3423572919-324x160.jpg "Intrexon Makes $11.63M Equity Payment in Ziopharm as Part of DNA-Based Anticancer Drug Deal")
![Proteins designed from artificial sequences rescued knockout bacterial strains.[drizzd-Fotolia.com]](https://www.genengnews.com/wp-content/uploads/2018/08/UGENWebsitepicturesTopStoriesJan2011Jan7_2010_21410201_ManLooksAtDNA_ArtificialProteinsSustainLife8375147852-324x160.jpg "Synthetic Proteins that Sustain Life Created")
